Single‐Dose Fluconazole versus Standard 2‐Week Therapy for Oropharyngeal Candidiasis in HIV‐Infected Patients: A Randomized, Double‐Blind, Double‐Dummy Trial

Abstract

A single dose of 750 mg of fluconazole was safe, well tolerated, and as effective as the standard 14-day fluconazole therapy in patients with HIV infection and acquired immunodeficiency syndrome who had oropharyngeal candidiasis coinfection.